CDH1 and breast neoplasm: Further, E-cadherin expression has been clearly shown to have no prognostic role in the intermediate stage II cases of breast cancer44 (which represent 30–60% of all cases, and are also the major source of inter-observer discrepancy among pathologists, making treatment decisions difficult), thus limiting its potential use as a common predictive factor applicable to all breast tumors.